SIGN UP

July 9, 2020 09:38 AM EDTUpdated 11:29 AM

The home run count: The $100M+ mega-round boom in biotech inspired a $7.3B feeding frenzy — so far this year

Over the last 6 months there’s been a blizzard of money piling up drifts of the green stuff through the biotech landscape. And the forecast …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE

ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

view job offer post your job now

TRENDING NOW

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

FDA approves first drug to treat ultra-rare lipid storage disease

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

FDA says Ozempic, Wegovy shortage is over

sponsored

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence